Effects of sitagliptin, acarbose and sulfonylureas on postprandial levels of GLP-1 and GIP in Japanese patients with type 2 diabetes

被引：0
|
作者：
Yabe, D. [1 ]
Watanabe, K. [1 ]
Sugawara, K. [1 ]
Kuwata, H. [1 ]
Kitamoto, Y. [1 ]
Sugizaki, K. [1 ]
Fujiwara, S. [1 ]
Hishizawa, M. [1 ]
Hyo, T. [1 ]
Kuwabara, K. [1 ]
Yokota, K. [1 ]
Iwasaki, M. [1 ]
Kitatani, N. [1 ]
Kurose, T. [1 ]
Seino, Y. [1 ]
机构：
[1] Kansai Elect Power Hosp, Div Diabet Clin Nutr & Endocrinol, Osaka, Japan
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
838
引用
收藏
页码：S342 / S342
页数：1
相关论文
共 50 条
  • [41] Renal effects of GLP-1 agonists in type 2 diabetes
    Elbert, Alicia
    Castellaro, Carlos
    Litwak, Leon
    Inserra, Felipe
    Wassermann, Alfredo
    Sinay, Isaac
    MEDICINA-BUENOS AIRES, 2022, 82 (04) : 576 - 590
  • [42] The Separate and Combined Impact of the Intestinal Hormones, GIP, GLP-1 and GLP-2, on Glucagon Secretion in Type 2 Diabetes
    Lund, Asger
    Vilsb'Oll, Tina
    Bagger, Jonatan Issing
    Holst, Jens Juul
    Knop, Filip Krag
    DIABETES, 2010, 59 : A75 - A75
  • [43] Long term effects of miglitol administration on GLP-1 and GIP responses after a mixed meal in Japanese type2 diabetic patients
    Sato, Takehiro
    Narita, Takuma
    Yokoyama, Hiroki
    Yamada, Yuichiro
    ENDOCRINE JOURNAL, 2010, 57 : S366 - S366
  • [44] The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
    Lund, Asger
    Vilsboll, Tina
    Bagger, Jonatan I.
    Holst, Jens J.
    Knop, Filip K.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2011, 300 (06): : E1038 - E1046
  • [45] The separate and combined impact of the intestinal hormones GIP, GLP-1 and GLP-2 on glucagon secretion in type 2 diabetes
    Lund, A.
    Vilsboll, T.
    Bagger, J. I.
    Holst, J. J.
    Knop, F. K.
    DIABETOLOGIA, 2010, 53
  • [46] Fasting Circulating GLP-1, GIP, PYY and PP Levels in Gestational Diabetes Mellitus
    Halvatsiotis, Panagiotis
    Karakitsos, Petros
    Panagopoulos, Periklis
    Patsouras, Konstantine
    Alepaki, Maria
    Batalias, Lambros
    Chrelias, Charalambos
    Kassanos, Demetrius
    Dimitriadis, George
    DIABETES, 2012, 61 : A340 - A340
  • [47] Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes
    Zambrowicz, Brian
    Ding, Zhi-Ming
    Ogbaa, Ike
    Frazier, Kenny
    Banks, Phillip
    Turnage, Anne
    Freiman, Joel
    Smith, Melinda
    Ruff, Dennis
    Sands, Arthur
    Powell, David
    CLINICAL THERAPEUTICS, 2013, 35 (03) : 273 - 285
  • [48] Ethanol exaggerates postprandial triglyceride levels and dealys GLP-1 responses in type-2 diabetic patients
    Dalgaard, M
    Thomsen, C
    Rasmussen, BM
    Holst, JJ
    Hermansen, K
    DIABETOLOGIA, 2001, 44 : A192 - A192
  • [49] Sitagliptin and Metformin Increase Active GLP-1 by Complementary Mechanisms in Treatment-Naive Patients with Type 2 Diabetes
    Migoya, Elizabeth
    Miller, Jutta
    Luo, Wen-Lin
    O'Neill, Edward
    Morrow, Linda
    Gutierrez, Maria
    Stoch, Aubrey
    Wagner, John A.
    DIABETES, 2010, 59 : A156 - A156
  • [50] Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
    Bahtiyar, Gul
    Pujals-Kury, Jean
    Sacerdote, Alan
    CURRENT DIABETES REPORTS, 2018, 18 (10)
12345